Where I see patients (1)
My reviews
Selected research
-
CD4+ CAR T-cell exhaustion associated with early relapse of multiple myeloma after BCMA CAR T-cell therapy.
Blood advances
-
Daratumumab in transplant-eligible patients with newly diagnosed multiple myeloma: final analysis of clinically relevant subgroups in GRIFFIN.
Blood cancer journal
-
Salvage therapies including retreatment with BCMA-directed approaches after BCMA CAR-T relapses for multiple myeloma.
Blood advances
Clinical trials
Contact me
- Request appointment
- Refer a patient
- (415) 353-2421
4.8